RecruitingNCT05248412

The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases

The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of Patients With Non-communicable Diseases (and Without COVID-19) : an In-depth Outcome and Health Economic Evaluation


Sponsor

The University of Hong Kong

Enrollment

250,000 participants

Start Date

Jun 21, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Objectives and aim: To evaluate the long-term spill-over (indirect) effect of Coronavirus disease (COVID-19) on health outcomes and healthcare utilization among people with non-communicable diseases and without COVID-19. Design: A population-based cohort study using electronic health records of the Hospital Authority (HA) clinical management system, economic modeling, and serial cross-sectional surveys on healthcare service utilization. Setting: HA public hospitals and outpatient clinics in Hong Kong Participants: People aged ≥ 18 years with a documented diagnosis of diabetes mellitus, hypertension, cardiovascular disease, cancer, chronic respiratory disease, and chronic kidney disease; without COVID-19; attending HA services between 2010 and 2024. Main outcome measures: All-cause mortality, disease-specific outcomes, healthcare service utilization, and costs. Methods: The annual incidence of each outcome in each year between 2010 and 2024 will be calculated. An interrupted time-series analysis to assess the changes in outcomes between pre-and-post-COVID-19 outbreak periods. Long term health economic impact of healthcare disruptions during the COVID-19 outbreak will be modeled using microsimulation. Multivariable Cox proportional hazards regression and Poisson/negative binomial regression to evaluate the effect of different modes of care on the risk of the outcomes. Implications: Findings will inform policies and practices on contingency care plans to avoid excessive morbidity and mortality and to assure the quality of care for patients with NCD as part of the territorial response to the health crisis.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is examining the long-term effects of the COVID-19 pandemic on people who already have chronic health conditions like diabetes, high blood pressure, heart disease, cancer, or kidney disease. Researchers want to understand how the pandemic disrupted healthcare access and health outcomes for these patients over time. **You may be eligible if...** - You are 18 or older - You have been diagnosed by a doctor with a chronic condition such as diabetes, high blood pressure, heart disease, cancer, chronic kidney disease, or a chronic breathing condition - You have visited a Hospital Authority clinic or hospital at least once between January 2010 and December 2024 - You can communicate in Chinese or English (for the survey portion) **You may NOT be eligible if...** - You have been diagnosed with COVID-19 Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCOVID-19 outbreaks

The intervention of the study is the COVID-19 outbreaks in Hong Kong. The pre-and post-COVID-19 outbreak periods will be defined as 1 January 2010 - 31 December 2019 and 1 January 2020 - 31 December 2024, respectively.


Locations(1)

Department of Family Medicine & Primary Care, LKS Faculty of Medicine, University of Hong Kong

Hong Kong, Hong Kong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05248412


Related Trials